Therapy of Anaphylaxis
- 10 November 1966
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 275 (19), 1059-1061
- https://doi.org/10.1056/nejm196611102751908
Abstract
THE anaphylactic reaction, often explosive in onset, may vary from mild pruritic symptoms to irreversible shock and fatal pulmonary insufficiency. These acute systemic manifestations follow readministration of an antigen to a previously sensitized person.PathogenesisAnaphylaxis is consequent to the release of highly reactive pharmacologic substances acting upon smooth muscle and vasculature. Histamine, serotonin, plasma kinins (kallidin I, kallidin II), and slow-reacting substance (SRS-A) are the primary mediators of the anaphylactic response. Histamine induces angioneurotic edema, hypotension and erythema in human beings when various histamine releasers are administered. Pretreatment with antihistamines will abolish these symptoms, but the drugs are ineffective . . .Keywords
This publication has 4 references indexed in Scilit:
- Clinical Detection of the Potential Allergic Reactor to Penicillin by Immunologic TestsJAMA, 1966
- REAGINIC ACTIVITY ASSOCIATED WITH IGG IMMUNOGLOBULINThe Journal of Experimental Medicine, 1966
- Systemic Anaphylaxis in ManPublished by American Medical Association (AMA) ,1965
- Fatal Systemic Anaphylaxis in ManNew England Journal of Medicine, 1964